Author： Adis International Limited
Publisher： Adis International
ISSN： 1172-0360
Source： Drugs & Therapy Perspectives, Vol.21, Iss.3, 2005-03, pp. : 7-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Maintenance of Remission in Crohns Disease: Current and Emerging Therapeutic Options
Drugs, Vol. 64, Iss. 10, 2004-01 ,pp. :
Access to resources
Recommend
Scheduled infliximab maintenance worthy for Crohn's disease in UK
Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. :
Certolizumab pegol effective maintenance therapy for Crohn's disease
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Infliximab maintenance therapy valuable strategy in Crohn's disease.
Inpharma, Vol. 1, Iss. 1313, 2001-01 ,pp. :
Teduglutide induces remission in patients with moderate-to-severe Crohn's disease
Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. :